Novel Combination Cancer Immunotherapy Summit 2024

Key Topics

• From the Lessons Learnt to Strategic Partnerships: Establishing the Roadmap Towards Novel & Synergistic Cancer Immunotherapy Combinations
• Improving Response Rate & Durability of Your Drugs Through Rational & Synergistic Combination Strategies
• Overcoming Complex Cancer Biology with Novel Multimodal Combinations Beyond Traditional Checkpoint Inhibitors
• Reducing Toxicity Whilst Improving Potency Through Effective Patient Selection, Protocol Design & Dosage Optimization
• Enhancing Patient Response Rate to Combination Therapies by Targeting the Tumor Microenvironment
• Navigating Patient Selection, Dosing & Regulatory Considerations to Ensure Clinical Success for Novel Combination Cancer Immunotherapies
• Achieving Better Translatability from Preclinical to Clinical Development with Smart Models, Resistance Investigation & Addressing Toxicity